The MarketWatch News Department was not involved in the creation of this content. The global industry was valued at US$ 38.9 Bn in 2022 and is expected to register a CAGR of 7.1% from 2023 to 2031.

The MarketWatch News Department was not involved in the creation of this content. AUSTIN, Texas and TOKYO, Oct. 3, 2025 /PRNewswire/ -- According to DataM Intelligence, the Active Pharmaceutical ...

Dublin, Dec. 03, 2025 (GLOBE NEWSWIRE) -- The "United States Active Pharmaceutical Ingredients (APIs) Market - Growth, Trends & Forecast 2025-2033" report has been added to ResearchAndMarkets.com's ...

Lakewood, CO, Jan. 08, 2025 (GLOBE NEWSWIRE) -- KRTL Holding Group Inc. (OTC: KRTL) announces that its wholly owned subsidiary, KRTL Biotech Inc., has acquired a 55% majority equity stake in Skidmore ...

As previously speculated, Teva Pharmaceutical Industries (NYSE:TEVA) will not undergo a split into two separate entities. On Tuesday, Teva’s Chief Executive, Richard Francis, said the company would ...

Red Light Holland completes initial phase of natural psilocybin extraction using imported truffles, in collaboration with PharmAla. The optimization process seeks to refine the scalable production of ...

The global industry was valued at US$ 38.9 Bn in 2022 and is expected to register a CAGR of 7.1% from 2023 to 2031. Demand for biologics, biosimilars, and other biopharmaceuticals is growing at a ...

(MENAFN- GlobeNewsWire - Nasdaq) The U.S. Active Pharmaceutical Ingredients (API) market is set to expand from $67.11 billion in 2024 to $117.86 billion by 2033, growing at a 6.46% CAGR. This ...

This partnership represents a key step in KRTL’s strategy to establish a strong presence in API distribution and real-world data-driven decision-making. By combining resources, expertise, and networks ...